Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992
Same author

Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.

Molecular pharmacology·1992
Same author

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Antimicrobial agents and chemotherapy·1992
Same author

Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1992
Same author

3'-C-branched 2'-deoxy-5-methyluridines: synthesis, enzyme inhibition, and antiviral properties.

Journal of medicinal chemistry·1992
Same author

Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives.

Journal of medicinal chemistry·1992
Same journal

Conformational changes upon pore blocker removal reveal conductive states of TMEM16A.

The Journal of general physiology·2026
Same journal

On the mechanism of hypomagnesemia with treatment-resistant seizures caused by variants of the Na+,K+-ATPase α1 subunit (ATP1A1).

The Journal of general physiology·2026
Same journal

Label-free real-time imaging of mitochondrial matrix volume changes and permeability transition in living cells.

The Journal of general physiology·2026
Same journal

Differential regulation of β1-dependent voltage shifts and kinetic modulation by an extracellular glutamate in NaV1.6 VSDIV.

The Journal of general physiology·2026
Same journal

Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity.

The Journal of general physiology·2026
Same journal

An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect.

The Journal of general physiology·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Nonviral interferon inducers.

T C Merigan1, E De Clercq, G H Bausek

  • 1Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305.

The Journal of General Physiology
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Non-viral agents, including synthetic polynucleotides, can stimulate interferon production. These interferon inducers show potential for therapeutic applications in disease prophylaxis and treatment.

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Interferon production can be induced by diverse microbial and nonmicrobial agents, extending beyond viral stimuli.
  • Nonmicrobial inducers encompass polyanions, mitogens, endotoxins, and antibiotics, each with distinct properties.
  • Polyanions, including polynucleotides, plastics, and polysaccharides, require a stable backbone and high anionic group density for activity.

Purpose of the Study:

  • To explore the range of nonmicrobial agents that stimulate interferon production.
  • To investigate the characteristics of effective synthetic polynucleotide inducers.
  • To elucidate the mechanism of interferon-stimulating RNA interaction with cells and its therapeutic potential.

Main Methods:

  • Categorization of nonmicrobial interferon inducers (polyanions, mitogens, miscellaneous).
  • Evaluation of synthetic polynucleotides, focusing on double-stranded RNA (dsRNA) efficacy.
  • Analysis of strategies to potentiate nucleotide inducers (e.g., polycations, metabolic antagonists).
  • Characterization of the three-step cellular interaction process with interferon-stimulating RNA.

Main Results:

  • Thermostable double-stranded RNA (dsRNA) demonstrated significantly higher activity compared to other RNA and DNA forms.
  • Potentiation of nucleotide inducers was achieved through various chemical modifications and co-administration strategies.
  • The interaction of interferon-stimulating RNA with cells involves surface binding, a temperature-dependent recognition step, and subsequent monomer utilization.

Conclusions:

  • Synthetic polynucleotides, particularly dsRNA, are potent stimulators of interferon production.
  • Understanding the cellular interaction mechanism of these inducers is crucial for optimizing their therapeutic application.
  • Animal models suggest that certain nucleotide inducers may hold clinical value for disease therapy and prophylaxis.